PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1930147
PUBLISHER: Fortune Business Insights Pvt. Ltd. | PRODUCT CODE: 1930147
The global sterilization services market is witnessing steady growth, driven by the increasing emphasis on infection prevention, rising surgical procedures, and the growing burden of hospital-acquired infections (HAIs). The market was valued at USD 3.26 billion in 2025 and is projected to grow to USD 3.37 billion in 2026, reaching USD 4.67 billion by 2034, exhibiting a CAGR of 4.17% during the forecast period (2026-2034). North America dominated the market, accounting for 38.80% share in 2025, supported by advanced healthcare infrastructure and strict infection control regulations.
Sterilization services play a critical role in healthcare by eliminating bacteria, viruses, and spores from medical devices and hospital environments, ensuring patient safety. The increasing trend of outsourcing sterilization processes by hospitals and medical device manufacturers is further supporting market growth.
Market Dynamics
Market Drivers
One of the major drivers fueling the sterilization services market is the rising prevalence of hospital-acquired infections (HAIs) such as surgical-site infections, catheter-associated urinary tract infections, and ventilator-associated pneumonia. According to the CDC (2024), nearly 4.0% of hospitalized patients in the U.S. are affected by HAIs at any given time. Similarly, the ECDC reported an HAI prevalence of 4.3% in the European Union in 2023.
Additionally, the growing geriatric population and increasing hospital admissions are increasing infection risks, driving demand for stringent sterilization protocols and professional sterilization services worldwide.
Market Restraints
The high cost of sterilization equipment remains a key restraint, particularly in emerging economies. Advanced autoclaves and sterilization systems can cost between USD 18,000 and USD 52,000, making adoption challenging for smaller healthcare facilities. High maintenance costs and the need for skilled professionals further limit market penetration in developing regions.
Market Opportunities
Emerging economies such as India and China present significant growth opportunities due to rising awareness of infection control, healthcare modernization, and increasing outsourcing of sterilization services. Government initiatives and partnerships, along with growing demand for advanced technologies such as electron beam (e-beam) sterilization, are expected to open new growth avenues for market players.
Market Challenges
Stringent regulatory requirements imposed by bodies such as the FDA, EMA, and EPA pose operational challenges. Regulations around sterilization agents like ethylene oxide (EtO), including EPA's proposed maximum EtO concentration limit of 600 mg/L by 2035, require service providers to invest heavily in compliance and advanced systems, which may slow market expansion.
Market Trends
A notable trend in the market is the technological advancement in sterilization techniques. Adoption of electron beam sterilization, hybrid steam-gas sterilization, and automated systems is increasing due to improved efficiency, reduced chemical usage, and better compliance tracking. In December 2024, BGS installed a high-power e-beam accelerator in the U.S., highlighting the shift toward advanced sterilization technologies.
By service type, contract sterilization services dominated the market with a 48.93% share in 2026, driven by increased outsourcing trends.
By delivery mode, off-site sterilization led the market with a 70.32% share in 2026, owing to cost efficiency and access to specialized facilities.
By method, steam sterilization accounted for the largest share (65.26% in 2026) due to its reliability and cost-effectiveness.
By end-user, hospitals & clinics dominated with a 60.29% share in 2026, driven by rising HAI cases and increased surgical volumes.
North America led the market with a value of USD 1.26 billion in 2025 and USD 1.31 billion in 2026, supported by high surgical volumes and advanced infection control practices.
Europe held the second-largest share, driven by service expansions in Germany, the U.K., and France.
Asia Pacific is expected to register the highest CAGR due to rising HAIs, expanding healthcare infrastructure, and increased investments in emerging economies.
Competitive Landscape
The market is semi-consolidated, with STERIS holding a dominant position due to its broad service portfolio and facility expansions. Other key players include Sterigenics U.S., LLC (Sotera Health), Ecolab, Medistri SA, and BGS, focusing on mergers, acquisitions, and capacity expansion.
Conclusion
The global sterilization services market is set to grow steadily, supported by rising hospital-acquired infections, increasing surgical procedures, and growing outsourcing trends in healthcare. While high equipment costs and regulatory complexities pose challenges, advancements in sterilization technologies and expanding opportunities in emerging markets are expected to sustain market growth. With strong demand from hospitals and medical device manufacturers, and continuous investments by key players, the market is expected to maintain stable expansion through 2034, reinforcing its critical role in global healthcare safety and infection prevention.
Segmentation By Service Type
By Delivery Mode
By Method
By End-user
By Region